Mycophenolate Mofetil Capsule
Product Images NDC 59651-624

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mycophenolate Mofetil (NDC 59651-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (250 mg (100 Capsules Bottle))

Package Label.principal Display Panel (250 mg (100 Capsules Bottle))
Label for Mycophenolate mofetil Capsules USP 250 mg by Aurobindo Pharma Limited. The label indicates 100 capsules, oral dosage form. It includes NDC 59651-624-01, distributor information (Aurobindo Pharma USA, Inc.), storage instructions, and a note for pharmacists to dispense the Medication Guide separately. The product is made in India.*
FDA Label Image

Str (Mycophenolate Mofetil Str)

Str (Mycophenolate Mofetil Str)
Chemical structure of Mycophenolate mofetil, showing its molecular framework with various functional groups including a phenol ring, methyl groups, and an ether-linked morpholine ring.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.